Schrödinger报告第四季度业绩

2026-02-26 05:24

Schrödinger press release (SDGR): Q4 Revenue of $87.2M (-1.2% Y/Y) beats by $3.54M.
Software revenue was $69.3 million, a 13% decrease, primarily due to the accelerated recognition of upfront revenue from multi-year agreements signed in 2024, partially offset by higher hosted revenue.
Drug discovery revenue was $18.0 million compared to $8.7 million.
Software gross margin was 81%.
Operating expenses were $74.5 million, a 12.2% decrease.
Other income, which includes gains/losses on equity investments, changes in fair value of such investments and interest income/expense, was $50.1 million.
Net income for the fourth quarter was $32.5 million, compared to a net loss of $40.2 million in the fourth quarter of 2024.

More on Schrödinger